Unstable angina/ NSTEMI resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Line 34: | Line 34: | ||
{{familytree | | | | | | | | | B01 | | | | | | B01= Determine Risk of adverse coronary event (TIMI) }} | {{familytree | | | | | | | | | B01 | | | | | | B01= Determine Risk of adverse coronary event (TIMI) }} | ||
{{familytree | | | | | |,|-|-|-|^|-|-|-|.| | | }} | {{familytree | | | | | |,|-|-|-|^|-|-|-|.| | | }} | ||
{{familytree | | | | | C01 | | | | | | C02 | | C01= LOW RISK | C02= HIGH RISK }} | {{familytree | | | | | C01 | | | | | | C02 | | C01= LOW RISK <br> Initial conservative strategy| C02= HIGH RISK Initial invasive strategy}} | ||
{{familytree | | | | | |!| | | | | | | |!| | | }} | {{familytree | | | | | |!| | | | | | | |!| | | }} | ||
{{familytree | | | | | D01 | | | | | | D02 | | D01= | {{familytree | | | | | D01 | | | | | | D02 | | D01= | ||
❑ Administer 300mg of copidogrel <br> | ❑ Administer 300mg of copidogrel <br> | ||
❑ Administer fondoparinaux or UFH in case of renal failure| | ❑ Administer fondoparinaux or UFH in case of renal failure| | ||
D02= | D02= ❑ Administer IV GP IIb/IIIa inhibitors (eptifibatide or tirofiban) <br> | ||
❑ Administer IV GP IIb/IIIa inhibitors (eptifibatide or tirofiban) <br> | |||
OR | OR | ||
❑ Administer Bivalirudin}} | ❑ Administer Bivalirudin}} |
Revision as of 21:30, 24 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Definition
Causes
Life Threatening Causes
Common Causes
Management
Diagnosis
Treatment
❑ Administer 300mg Aspirin immediately after hospital admission ❑ Administer oxygen in patients with saturation <90% | |||||||||||||||||||||||||||||||||||||||||
Determine Risk of adverse coronary event (TIMI) | |||||||||||||||||||||||||||||||||||||||||
LOW RISK Initial conservative strategy | HIGH RISK Initial invasive strategy | ||||||||||||||||||||||||||||||||||||||||
❑ Administer 300mg of copidogrel ❑ Administer fondoparinaux or UFH in case of renal failure | ❑ Administer IV GP IIb/IIIa inhibitors (eptifibatide or tirofiban) OR ❑ Administer Bivalirudin | ||||||||||||||||||||||||||||||||||||||||